Coronary bifurcation lesion (CBL) is a narrowing of coronary artery adjacent to, and/or involving the origin of, a significant side branch. CBLs encompass a wide variety of anatomic subsets and clinical scenarios, from left-main bifurcation with a significant amount of myocardium at risk to a small branching lateral branch with a negligible amount of myocardium at risk. CBLs account for approximately 15% to 20% of all cases requiring percutaneous coronary intervention (PCI). [1] Catheter-based therapies can be technically challenging in terms of adapting available devices and strategies to the anatomy to restore vessel patency while preserving the fractal geometry of the bifurcation itself. Often, PCI of a CBL is associated with a lower prevalence of procedural success and higher prevalence of complications, thrombosis, and restenosis, than PCI of a non-bifurcation. Thus, safe and efficacious treatment strategies for CBLs are important.Considerable progress has been made in CBL treatment thanks to rapid development of stenting strategies/technologies, a new generation of antiplatelet agents, intravascular imaging and coronary physiology, as well as deeper understanding of the abnormal flow dynamics around bifurcated areas. [2,3] These developments have resulted in fewer adverse clinical outcomes. Here, we discuss techniques and evidence for PCI of CBLs.